SB

Sudhir Bhikaji Bhambar

Active Director Designated Partner DIN 10146276
DIN 10146276 First appointment May 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sudhir Bhikaji Bhambar

Data last updated:

Sudhir Bhikaji Bhambar is a Designated Partner at Curanest Pharma Llp (since 2023). The company operates in Business Services.

DIN 10146276
Primary Designation Designated Partner
Industry Business Services
First Appointment 03 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner03 May 20232023Active

Board colleagues of Sudhir Bhikaji Bhambar

NameDINCompanyDesignation
Geeta Tushar Deore10146278Curanest Pharma LlpDesignated Partner
Nikhil Subhash Aher10146277Curanest Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Curanest Pharma Llp
Premium access

Shareholding and investment profile for Sudhir Bhikaji Bhambar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhir Bhikaji Bhambar

Sudhir Bhikaji Bhambar currently holds 1 directorship: Curanest Pharma Llp (Designated Partner, since 03 May 2023).

Sudhir Bhikaji Bhambar was first appointed on 03 May 2023 as Designated Partner at Curanest Pharma Llp.

The current boards of Sudhir Bhikaji Bhambar's companies include Geeta Tushar Deore (Curanest Pharma Llp), Nikhil Subhash Aher (Curanest Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available